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Abstract: Depression is common in patients with Parkinson’s disease (PD) and has been 
identiﬁ  ed as the main factor negatively impacting quality of life. It has been reported that 
depression in PD is under-recognized and under-treated. We report on 90 patients with PD 
who completed the Geriatric Depression Rating Scale (GDS). Thirteen subjects (14%) scored 
above 15, the proposed cut-off for diagnosing depression in this illness. Detailed medical record 
review for these subjects revealed that depression was recognized and treated in only about 
one-half of the cases. Comparison of mean subscale scores between subjects scoring above 
and below the cut-off for diagnosis of depression revealed that each of 6 proposed subscales 
effectively distinguished the two groups. Review of individual items demonstrated that many 
of the subjects endorsed low energy, regardless of whether they were depressed. This study 
supports the notion that efforts should be made to educate patients, caregivers and physicians 
about identifying depression in PD. The routine use of a depression rating scale may facilitate 
the recognition of depression in this illness.
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Introduction
The most commonly recognized clinical features of Parkinson’s disease (PD) involve 
the motor system and include bradykinesia, rigidity, tremor and postural instability. 
Psychiatric symptoms are, however, quite common in this illness. About 50% of 
patients with PD experience depression (Dooneif et al 1992). Although major depres-
sion occurs in PD, surveys indicate that the majority of depressed PD patients have 
less severe forms, such as minor depression, dysthymic disorder and subsyndromal 
symptoms (Dooneif et al 1992; Liu et al 1997; Starkstein et al 1998). Recent evidence 
indicates that depression is the major factor negatively affecting quality of life in PD 
and that emotional symptoms, including depression, are the main cause of caregiver 
distress (Aarsland et al 1999; Kuopio et al 2000; The Global Parkinson’s Disease 
Survey 2001). Thus, effective treatment of co-morbid depression has the potential of 
improving overall function and quality of life for both patients and caregivers.
A recent international survey of patients with PD, caregivers, and physicians found 
that although depression was the factor most signiﬁ  cantly associated with patient 
quality of life, it is rarely reported by patients to their physicians and may not be rec-
ognized by patients themselves (Kuopio et al 2000; The Global Parkinson’s Disease 
Survey 2001). A study by Shulman et al (2002) demonstrated that neurologists failed 
to identify the presence of depression in patients with PD more than half of the time. 
A recently published report by an NIH working group (Marsh et al 2006) highlighted 
the complexities associated with the diagnosis of depression in PD and pointed out 
issues that can make the recognition of depression difﬁ  cult: 1) potential overlap between 
the signs and symptoms of depression and those of PD itself (eg, decreased facial 
expression, slowness), 2) the possibility that depression in PD may have an atypical 
proﬁ  le of symptoms, and 3) depression of lesser severity (dysthymia, minor depression, Neuropsychiatric Disease and Treatment 2006:2(3) 350
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subsyndromal depression) is common and may be overlooked 
in PD. Another possibility for underdiagnosis is that patients 
and family members (and perhaps physicians) may accept 
low mood, pessimism, hopelessness, and other symptoms 
of depression as a normal response to having a neurodegen-
erative illness rather than as features of an associated mood 
disorder.
One suggested approach toward better recognition of 
depression in PD is the routine use of depression rating 
scales. A self-report scale that has been used in PD patients 
is the Geriatric Depression Scale (GDS) (Yesavage et al 
1983; Ertan et al 2005). The GDS (Yesavage et al 1983) 
does not emphasize “somatic” symptoms of depression, 
which may lessen the potential confounds in PD patients, 
and has, in fact, been shown to be a valid and reliable 
indicator of depression in PD (Ertan et al 2005). Sensitivity 
and speciﬁ  city analyses of the 30 item GDS in PD showed 
that cut-off scores of 9/10 could be used to screen for 
depression and 14/15 or 15/16 for diagnostic purposes 
(Ertan et al 2005). The GDS was designed to yield a single 
score and is generally considered a unidimensional scale. 
However, factor analyses have been performed (using a 
non-PD sample) (Adams et al 2004), and the following 
6 subscales have been proposed: 1) dysphoria (mood), 
2) dysphoria (hopelessness), 3) withdrawal/apathy/vigor, 
4) anxiety, 5) cognitive, and 6) agitation.
In our previously reported study of mood ﬂ  uctuations in 
PD, we noted that subjects with PD achieved signiﬁ  cantly 
higher scores on the GDS compared to age and gender 
matched healthy controls (Richard et al 2004). In the 
present study, we report the results of 1) medical record 
reviews for subjects scoring within the depressed range 
on the GDS, 2) a comparison between this group and 
subjects scoring below this level with regard to mean 
scores on each of the 6 subscales (to determine if some 
are more useful than others in distinguishing patients with 
and without depression), and 3) an analysis of the percent-
ages of subjects from each group who endorsed individual 
rating scale items.
Methods
As part of a diary study of mood ﬂ  uctuations, 90 consecutive 
patients with idiopathic PD who were patients from a spe-
cialty PD clinic completed the GDS (Yesavage et al 1983; 
Ertan et al 2005). Subjects were not selected for depres-
sive symptoms. Study procedures are described in detail 
in the original article (Richard et al 2004). Subjects were 
divided into two groups based on their total GDS scores. 
Subjects with total GDS scores   15 were considered 
“depressed”.
An in-depth medical record review was performed for all 
subjects scoring within the depressed range on the GDS. The 
groups were then compared with regard to mean scores on 
each of 6 proposed GDS subscales using the Mann-Whitney 
test for nonparametric data. For each item, the percentage of 
subjects answering in the depressed manner was calculated 
for both groups.
Results
90 PD patients completed the GDS. Subjects were 55% 
women, with an average age of 66.7 years and a mean Hoehn 
and Yahr stage of 2.2. GDS scores ranged from 0 to 28, with 
a mean score of 9.6 (sd = 7.12) and a median score of 9.0. 
The distribution of the scores is depicted in Figure 1. Thirteen 
subjects (14%) scored greater than 15 and comprised the 
“depressed” group for the purpose of analyses.
Results from a detailed chart review of the 13 patients in 
the depressed group are summarized in Table 1. According 
to the medical records, 7 of these patients were diagnosed 
with a mood disorder, 6 of whom were being treated with 
a medication for depression. We also reviewed the medical 
records of the 2 subjects with scores of 15 (not included in 
Table 1), neither of whom had medical record evidence of 
depression diagnosis or treatment.
Statistical analyses demonstrated that mean scores for 
each of the 6 subscales were signiﬁ  cantly different between 
the depressed and nondepressed groups (p   0.001) 
(Table 2).
The percentages of subjects from each group who 
responded in the “depressed” manner on each GDS item are 
outlined in Table 3. A minority of patients reported worrying 
about the past, even among the depressed subjects. On the 
other hand, most patients reported low energy, regardless of 
their total GDS Score.
Conclusion
About half of PD patients completing the GDS in our study 
scored above 9, the cut-off recommended for screening 
purposes with this depression rating scale which has been 
deemed valid and reliable in PD (Ertan et al 2005; Yesavage 
et al 1983). Although this ﬁ  nding is based on patient self-
report and may be biased towards more complicated cases 
seen in a PD specialty clinic, the observed frequency of 
depression is similar to previously reported rates in PD 
(Dooneif et al 1992: The Global Parkinson’s Disease 
Survey 2001).Neuropsychiatric Disease and Treatment 2006:2(3) 351
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Thirteen of the 90 patients (14%) scored above 15, the 
recommended cut-off score for the diagnosis of depression 
in PD, also reﬂ  ecting scores greater than one standard devia-
tion above the mean (9.6 ± 7.1) for our sample. Medical 
record review revealed that depression was diagnosed and 
treated in about half of these subjects. These results were 
consistent with those of other studies suggesting that there 
is inadequate recognition of depression by both PD patients 
(Kuopio et al 2000; The Global Parkinson’s Disease Survey 
2001) and their physicians (Shulman et al 2002). Our study 
suggests that it is not just mild depressive symptoms that 
are under-recognized and untreated. Thus, the relatively 
mild severity of depression in many cases of PD is not a 
satisfactory explanation for its under-recognition.
Our analysis of subscale scores revealed that each 
of the six subscales effectively distinguished patients 
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Figure 1 The distribution of GDS scores among the 90 subjects.   The mean GDS score was 9.6 (sd 7.12) and the median score was 9.0.
Abbreviation: GDS, Geriatric Depression Rating Scale.
Table 1 Characteristics of subjects scoring above 15 on the GDS
Age/Sex Antidepressant medications GDS Chart comments
39 F venlafaxine 150 mg q day
buproprion 150 mg tid
28 Neurologist notes h/o severe depression, worsening, psychiatrist involved
78 F sertraline 75 mg q day 27 Neurologist aware of depression, recommends increasing sertraline dosage
87 F None 27 No mention of depression
54 F nortriptyline 25 mg q day
trazodone 50 mg q day
citalopram 20 mg q day
25 Neurologist repeatedly comments about depression and anxiety, noting that 
it is difﬁ  cult to treat, psychiatrist involved
62 M None 24 No mention of depression
78 M None 23 Occasional mention of depression in chart by various providers over 
several years. Never diagnosed with or treated for depression
52 F None 22 Neurologist writes to primary physician that patient has depression and 
panic, recommends “an SSRI”
78 M None 22 No mention of depression
63 F imipramine 20 mg q day (for sleep) 20 Neurologist aware of depression history.
Pt. had been on sertaline and lorazepam in past with good response.
Reason for d/c of these agents several months prior to rating scale not 
documented
46 M paroxetine 20 mg q day 18 Depression recognized, paroxetine started one year earlier
76 F paroxetine 20 mg q day 17 Depression recognized, paroxetine started ﬁ  ve years earlier, dosage 
increased from 10mg/day to 20mg/day one year after medication started. 
Notes in chart around time of study do not mention depression
44 F None 17 No mention of depression in chart
72 M sertraline 100 mg/day 17 Note in chart around time of study states “depression is well-controlled on Zoloft”Neuropsychiatric Disease and Treatment 2006:2(3) 352
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scoring within the depressed range from those scoring 
below the cut-off. Review of individual rating scales 
demonstrated that worrying about the past (guilt, self-
reproach) is relatively uncommon among PD patients 
whether depressed or not. Diminished energy is a common 
complaint, even among those who do not score within the 
depressed range. These ﬁ  ndings are in keeping with the 
notion that depression in PD may have atypical features 
(low guilt) (Cummings 1992). A possible explanation 
for why low energy may not be a speciﬁ  c symptom of 
depression is recent information indicating that fatigue is 
a common and independent feature of PD (Friedman and 
Friedman 2001; Alves et al 2004).
The results of this study support the view that efforts 
are needed to better educate patients, family members 
and physicians about depression in PD (Aarsland et al 
1999; Kuopio et al 2000; The Global Parkinson’s Disease 
Survey 2001). Our study suggests that the routine use of 
a self-rating depression scale may increase the likelihood 
of identifying symptoms of depression.
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